Search

Mary Mosher

Examiner (ID: 8389)

Most Active Art Unit
1648
Art Unit(s)
1813, 1815, 1643, 2899, 1648, 1641, 1804, 1609, 1805
Total Applications
1434
Issued Applications
907
Pending Applications
126
Abandoned Applications
404

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5464393 [patent_doc_number] => 20090324593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/457447 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 42848 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324593.pdf [firstpage_image] =>[orig_patent_app_number] => 12457447 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/457447
Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof Jun 10, 2009 Abandoned
Array ( [id] => 6024301 [patent_doc_number] => 20110052627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE' [patent_app_type] => utility [patent_app_number] => 12/937412 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052627.pdf [firstpage_image] =>[orig_patent_app_number] => 12937412 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937412
RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE Jun 7, 2009 Abandoned
Array ( [id] => 4598622 [patent_doc_number] => 07976850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Pox viridae treatment' [patent_app_type] => utility [patent_app_number] => 12/474331 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6272 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/976/07976850.pdf [firstpage_image] =>[orig_patent_app_number] => 12474331 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474331
Pox viridae treatment May 28, 2009 Issued
Array ( [id] => 8469627 [patent_doc_number] => 08298805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Signal for packaging of influenza virus vectors' [patent_app_type] => utility [patent_app_number] => 12/470287 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 42 [patent_no_of_words] => 24328 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12470287 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/470287
Signal for packaging of influenza virus vectors May 20, 2009 Issued
Array ( [id] => 5490357 [patent_doc_number] => 20090291428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/469535 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 15957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291428.pdf [firstpage_image] =>[orig_patent_app_number] => 12469535 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469535
COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS May 19, 2009 Abandoned
Array ( [id] => 6340234 [patent_doc_number] => 20100247572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'VIRUSES ENCODING MUTANT MEMBRANE PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/467492 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15738 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247572.pdf [firstpage_image] =>[orig_patent_app_number] => 12467492 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467492
VIRUSES ENCODING MUTANT MEMBRANE PROTEIN May 17, 2009 Abandoned
Array ( [id] => 5551776 [patent_doc_number] => 20090285762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'IMAGING METHODS AND COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING' [patent_app_type] => utility [patent_app_number] => 12/466122 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9441 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285762.pdf [firstpage_image] =>[orig_patent_app_number] => 12466122 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/466122
Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging May 13, 2009 Issued
Array ( [id] => 5984826 [patent_doc_number] => 20110097417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'MELAN-A-CARRIER CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/463985 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 47822 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097417.pdf [firstpage_image] =>[orig_patent_app_number] => 12463985 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/463985
MELAN-A-CARRIER CONJUGATES May 10, 2009 Abandoned
Array ( [id] => 4624019 [patent_doc_number] => 08003314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Methods for direct fluorescent antibody virus detection in liquids' [patent_app_type] => utility [patent_app_number] => 12/425256 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30310 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003314.pdf [firstpage_image] =>[orig_patent_app_number] => 12425256 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/425256
Methods for direct fluorescent antibody virus detection in liquids Apr 15, 2009 Issued
Array ( [id] => 6038451 [patent_doc_number] => 20110091500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Inactivated Live-Attenuated Bluetongue Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 12/988282 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6132 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091500.pdf [firstpage_image] =>[orig_patent_app_number] => 12988282 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/988282
Inactivated Live-Attenuated Bluetongue Virus Vaccine Apr 15, 2009 Abandoned
Array ( [id] => 5457859 [patent_doc_number] => 20090258011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Antibodies against west nile virus and therapeutic and prophylactic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/385346 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 49499 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258011.pdf [firstpage_image] =>[orig_patent_app_number] => 12385346 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/385346
Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof Apr 5, 2009 Issued
Array ( [id] => 8027881 [patent_doc_number] => 08143020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Enhanced metabolite generation' [patent_app_type] => utility [patent_app_number] => 12/417881 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5222 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143020.pdf [firstpage_image] =>[orig_patent_app_number] => 12417881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417881
Enhanced metabolite generation Apr 2, 2009 Issued
Array ( [id] => 6479557 [patent_doc_number] => 20100041740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'FLU VACCINES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/417556 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20439 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041740.pdf [firstpage_image] =>[orig_patent_app_number] => 12417556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417556
Flu vaccines and methods of use thereof Apr 1, 2009 Issued
Array ( [id] => 5385241 [patent_doc_number] => 20090226486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'N protein mutants of porcine reproductive and respiratory syndrome virus' [patent_app_type] => utility [patent_app_number] => 12/383937 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11464 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226486.pdf [firstpage_image] =>[orig_patent_app_number] => 12383937 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/383937
N protein mutants of porcine reproductive and respiratory syndrome virus Mar 29, 2009 Issued
Array ( [id] => 6349444 [patent_doc_number] => 20100249043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/413436 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3043 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249043.pdf [firstpage_image] =>[orig_patent_app_number] => 12413436 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/413436
COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH Mar 26, 2009 Abandoned
Array ( [id] => 6202309 [patent_doc_number] => 20110065095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'ANTI-(INFLUENZA A VIRUS SUBTYPE H5 HEMAGGLUTININ) MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/934908 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12529 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065095.pdf [firstpage_image] =>[orig_patent_app_number] => 12934908 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/934908
Anti-(influenza a virus subtype H5 hemagglutinin) monoclonal antibody Mar 25, 2009 Issued
Array ( [id] => 6353429 [patent_doc_number] => 20100086564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'West Nile Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 12/409120 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5765 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086564.pdf [firstpage_image] =>[orig_patent_app_number] => 12409120 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/409120
West nile virus vaccine Mar 22, 2009 Issued
Array ( [id] => 6228909 [patent_doc_number] => 20100183647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor' [patent_app_type] => utility [patent_app_number] => 12/382425 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 34955 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183647.pdf [firstpage_image] =>[orig_patent_app_number] => 12382425 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/382425
Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor Mar 15, 2009 Abandoned
Array ( [id] => 6202307 [patent_doc_number] => 20110065093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS' [patent_app_type] => utility [patent_app_number] => 12/921865 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7279 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065093.pdf [firstpage_image] =>[orig_patent_app_number] => 12921865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921865
NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS Mar 8, 2009 Abandoned
Array ( [id] => 7987219 [patent_doc_number] => 08075903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4' [patent_app_type] => utility [patent_app_number] => 12/398043 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 30973 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/075/08075903.pdf [firstpage_image] =>[orig_patent_app_number] => 12398043 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/398043
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Mar 3, 2009 Issued
Menu